Anticoagulation reduced adverse clinical events in patients with atrial fibrillation at intermediate stroke risk, without an ...

A novel ultrasound-derived score combined with liver stiffness measurement can identify both MASH and fibrosis, potentially ...

Among adult veterans, oseltamivir treatment initiated within 6 hours of influenza diagnosis is associated with a reduced risk ...

Antiviral treatment started within 48 hours of symptom onset is linked to a reduced risk for hospitalization among pediatric ...

The FDA has approved brepocitinib (Lisraya), an oral JAK inhibitor, for the treatment of dermatomyositis, a rare autoimmune ...

Older adults with type 2 diabetes have faster cortical thinning in several brain regions and greater decline in processing ...

Over a median follow-up of 210.1 weeks, tirzepatide was found to be noninferior to dulaglutide, with an 8% lower rate of MACE-3. The estimated hazard ratio for time to first MACE was 0.92 (95.3% CI, 0 ...

As the first second-generation INSTI approved for newborns with HIV, this approval allows for a simpler, more robust antiretroviral therapy regimen than existing standard of care.

In a phase 3 trial, adding a combo of two traditional Chinese meds to metformin reduced A1c and improved lipid measure in ...

Vitamin B3 supplementation improves nailfold capillary patterns in patients with Raynaud phenomenon, with those with primary ...

The assay’s significant limitation is its inability to assess drug resistance for integrase inhibitors, including ...

Visible hyperpigmentation may mask persistent erythema and should not be assumed to indicate resolved inflammation,’ ...